PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic study identifies optimal gene targets for new colon cancer test

2012-04-04
(Press-News.org) ROCHESTER, Minn. -- A study presented today by Mayo Clinic researchers at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago identified two genes that are optimal targets to be analyzed in a new noninvasive test for colorectal cancer developed by Mayo Clinic, in collaboration with Exact Sciences Corporation. The test uses a small sample of a patient's stool to check for specific DNA changes, known as gene methylation, that occur as cancer develops. The test can quickly detect both early stage cancer and precancerous polyps.

"This study provided a means to refine our stool test and to minimize false-positive results, which can lead to unnecessary expense and cause patients undue stress," says principal investigator David Ahlquist, M.D., of Mayo Clinic.

The study involved 500 patients, ages 50 to 80, who had no symptoms and who recently had a colonoscopy with normal results. Researchers examined genes from each patient and found methylation increased among older patients. However, two genes were affected only minimally by age, making them optimal targets for the stool test. Importantly, the methylated genes were not affected by any other patient characteristics, including race, ethnicity, gender, geographic residence, family history of colon cancer, or previous polyps.

In addition, results of the stool test were consistent, regardless of whether patients smoked, consumed alcohol, took aspirin or were obese.

"Other than age, common clinical factors had no impact on the degree of methylation detected by the stool test," Dr. Ahlquist says. "This is very good news from the point of view of clinical practicality because the test applies to all patients, and they don't need to change medications or any habits for the results to be accurate."

A lab that reviews the test results can easily adjust the range of "normal" for older patients who undergo the test.

Previous studies by Mayo Clinic and Exact Sciences Corporation have shown that the stool test has high sensitivity for cancer and precancerous polyps.

"Because the test detects polyps, widespread screening with this test has potential to prevent colorectal cancer from forming in the first place, just as the Pap smear has prevented cervical cancer," Dr. Ahlquist says.

The stool test is being evaluated in a large multicenter study in the United States and Canada, involving 10,000 patients at more than 60 medical centers. If the test is approved by the Food and Drug Administration, it could become available to patients as early as mid-2013.

INFORMATION:

Mayo Clinic and Dr. Ahlquist have a financial interest in the technology referenced in this announcement.

As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.org/about/ and www.mayoclinic.org/news.

END



ELSE PRESS RELEASES FROM THIS DATE:

Changes in asthma treatment improve wait time and patient care in Emergency

2012-04-04
OTTAWA, Canada -- Dr. Roger Zemek, Director of Emergency Research at the CHEO Research Institute and ED physician, and assistant professor in the Faculty of Medicine at the University of Ottawa, has overseen the creation and implementation of a Medical Directive that now empowers nurses to administer an oral steroid treatment, which has reduced wait time and improved patient care. This research is published today in Pediatrics. Asthma is the most common chronic illness in children requiring a visit to Emergency. Every year, the Children's Hospital of Eastern Ontario (CHEO) ...

New drug prevents spread of human prostate cancer cells

2012-04-04
CHICAGO --- A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the "go" switch in the cancer cells and immobilizes them. Prostate cancer is the second-leading cause of cancer death in North American males. Death is mainly caused by metastasis, prostate cancer cells moving out of prostate tissue and spreading to other organs. "This is an extremely promising new therapeutic that locks down aggressive prostate cancer cells ...

Gladstone scientists find increased ApoE protein levels may promote Alzheimer's disease

2012-04-04
SAN FRANCISCO, CA—April 3, 2012—Scientists at the Gladstone Institutes have enhanced our understanding of how a protein linked to Alzheimer's disease keeps young brains healthy, but can damage them later in life—suggesting new research avenues for treating this devastating disease. In the Journal of Neuroscience, available online today, researchers in the laboratory of Yadong Huang, MD, PhD, have uncovered the distinct roles that the apoE protein plays in young vs. aging brains. These findings, which could inform the future of Alzheimer's drug development, come at a time ...

Pollen can protect mahogany from extinction

2012-04-04
New research from the University of Adelaide could help protect one of the world's most globally threatened tree species - the big leaf mahogany - from extinction. Big leaf mahogany (Swietenia macrophylla) is the most prized mahogany timber around the world. It is at risk of extinction in its native habitats because of the timber trade, particularly in Central and South America. To better understand how such a threatened species can be brought back from the brink of extinction, scientists from the University of Adelaide's Environment Institute have studied the important ...

Stomata development in plants unraveled -- a valuable discovery for environmental research

2012-04-04
Plants breathe through stomata Plant leaves are protected from drying out by an airtight wax layer. They breathe and release water through microscopic pores called stomata. Every year 40% of atmospheric CO2 and twice the volume of water found in our atmosphere pass through these pores. This means that stomata are not only important for plant development but also for our climate! It's no surprise then that these pores appear to be strictly regulated by plants. Stomata react extremely fast to internal plant signals and changes in the environment. When rain is scarce, ...

A study confirms that long commercials evoke stronger emotions

A study confirms that long commercials evoke stronger emotions
2012-04-04
What effect does a TV advert have on a viewer? How does it bring about a change in their knowledge, emotions or intentions? These questions have existed alongside advertising ever since it began. Through a psycho-physiological study developed jointly by El Bureau de la Comunicación, the Tecnalia Centre for Applied Research, and the UPV/EHU, it has been possible to measure the emotional response of a person to a series of television adverts. The aim of the study, carried out for the first time entirely in the Basque Autonomous Community (region), was to shed some light ...

Viral replication impedes the efficacy of a targeted therapy against virus-induced lymphomas

2012-04-04
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis. Researchers at the University of Helsinki discovered that spontaneous induction of KSHV lytic replication in tumors drastically attenuated the p53-dependent apoptotic response not only to a targeted therapy (Nutlin-3) but also to genotoxic anti-cancer agents. The findings by the research groups of Päivi Ojala (Institute of ...

Serious complications after esophageal surgery cause lasting health problems in long-term survivors

2012-04-04
Oesophageal cancer is a very serious form of cancer that, if not fatal, requires extensive surgery. A new study from Karolinska Institutet in Sweden shows that when serious complications arise after surgery for oesophageal cancer, many patients suffer other health problems, such as breathlessness, fatigue, insomnia and eating problems, for five years afterwards. "Patients who suffer serious post-operative complications after surgery for oesophageal cancer need very close, long-term monitoring so that any problems that arise can be identified and targeted quickly," says ...

Is bioenergy expansion harmful to wildlife?

2012-04-04
Despite the predicted environmental benefits of biofuels, converting land to grow bioenergy crops may harm native wildlife. Researchers at the Helmholtz Centre for Environmental Research in Leipzig have developed a way to study the effects of increased energy crop cultivation on farmland bird populations. "The Skylark is an indicator species for agricultural areas because it occupies many habitats of the wider countryside around the globe, breeds on the ground within fields and feeds mostly on insects" notes lead researcher, Jan Engel. "Improving the habitat suitability ...

New immune defense enzyme discovered

New immune defense enzyme discovered
2012-04-04
Neutrophil granulocytes comprise important defences for the immune system. When pathogenic bacteria penetrate the body, they are the first on the scene to mobilise other immune cells via signal molecules, thereby containing the risk. To this end, they release serine proteases – enzymes that cut up other proteins to activate signal molecules. Scientists at the Max Planck Institute of Neurobiology in Martinsried have now discovered a new serine protease: neutrophil serine protease 4, or NSP4. This enzyme could provide a new target for the treatment of diseases that involve ...

LAST 30 PRESS RELEASES:

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

[Press-News.org] Mayo Clinic study identifies optimal gene targets for new colon cancer test